XM does not provide services to residents of the United States of America.

Credits tied to biogas slump on proposed waiver to supply mandates



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Credits tied to biogas slump on proposed waiver to supply mandates</title></head><body>

D3 RINs fall to over one-year low after EPA proposes partial waiver

Proposal follows petition by refining lobby arguing EPA mandates for 2024 are too high

Analyst says small 2024 shortfall is likely, but low probability of waiver credits

By Shariq Khan

NEW YORK, Nov 14 (Reuters) -Prices for cellulosic biofuel production credits fell to their lowest in over a year this week after the U.S. Environmental Protection Agency (EPA) proposed a partial waiver to its supply mandates for 2024, according to traders and market participants.

The proposal, submitted for government approval on Tuesday, follows a petition by industry lobby group American Fuel & Petrochemicals Manufacturers on Nov. 1 arguing that EPA's supply mandates for this year were too high to meet. A similar petition by AFPM on last year's mandates was denied by the EPA.

It comes amid an uncertain future for carbon credit markets after Donald Trump's victory in the U.S. presidential election this month, which made market participants bet that exemptions to renewable fuel mandates will become easier to attain.

The EPA sets annual mandates for low-carbon alternatives to be added in the U.S. fuel mix. Mandates for this year required 1.09 billion gallons of biofuels made from cellulosic sources like leaves and stems, and 1.38 billion gallons in 2025.

D3 Renewable Identification Numbers (RINs) tied to cellulosic biofuels fell from over $3 per gallon each to $2.70 each on Wednesday, the lowest since October 2023, traders said.

RINs are used by the EPA to track compliance with its mandates. Each gallon of renewable fuels generates a RIN, and suppliers who meet their targets can sell excess RINs to those falling short.

Around 97% of D3 RINs are tied to the production of biogas, a renewable energy source derived from agricultural waste, according to estimates from AEGIS Hedging, a liquidity provider for energy markets.

Data on D3 RINs generated so far indicate a shortfall is likely in 2024, Zander Capozzola, vice president of renewable fuels at AEGIS told Reuters by phone. He cautioned the shortfall is unlikely to require as large an adjustment to EPA's mandates as the market reaction suggests.

AFPM's petition had asked the EPA to issue cellulosic waiver credits, which are an alternative mode of compliance in lieu of RINs.

"They will likely trim the volumes for 2024 a bit, but we see a low probability of waiver credits," Capozzola said.

Mandates for 2025 are not yet expected to be altered, he said separately in a LinkedIn post.



Reporting by Shariq Khan in New York; Editing by Chizu Nomiyama

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.